Dan-Inject ApS: Financial statements 2022
CVR: 39736497
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Dan-Inject ApS (CVR 39736497) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,350,982 and a net result of DKK 1,466,464 compared with DKK 1,038,400 the year before. That is an increase of 2.5% compared with the year before. Equity in the 2022 report amounted to DKK 3,562,706. The solvency ratio was 18.7%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 7,350,982
- Profit/Loss
- DKK 1,466,464
- Equity
- DKK 3,562,706
- Total Assets
- DKK 19,089,602
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 7.4 mio. | 1.5 mio. | 3.6 mio. | 7 |
| 2021 | - | 7.2 mio. | 1 mio. | 2.5 mio. | 7 |
| 2020 | - | 6.3 mio. | 782 t. | 1.5 mio. | 6 |
Keep an eye on Dan-Inject ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Dan-Inject ApS has published its annual report for 2021. Gross profit came to DKK 7,174,943, and the net result was DKK 1,038,400.
About Dan-Inject ApS
Dan-Inject ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2018. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SJS 2018 ApS. The management consists of Steffen Stræde. The board consists of Jesper Stagegaard, Steffen Stræde and Søren Ravn Jensen. The company is owned by RAVN JENSEN HOLDING A/S, Saathi Holding ApS and Saga Holding ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 7,084,282 and a net result of DKK 440,640 compared with DKK 69,179 the year before. Equity in the 2025 report amounted to DKK 5,830,336.